P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessPoster presentation
P04-37. Kinetic and thermodynamic factors determine HIV-1 
neutralizing potency of MPER-specific antibodies
C Ruprecht*, L Berlinger and A Trkola
Address: Institute of Medical Virology, University of Zurich, Zurich, Switzerland
* Corresponding author    
Background
A considerable effort in the development of HIV vaccines
has been directed towards eliciting neutralizing antibody
responses that match the activities of the membrane-prox-
imal external region (MPER) specific monoclonal anti-
bodies 2F5 and 4E10. Recent years have broadened our
knowledge in the structural composition of the MPER
region, its accessibility for antibody attack, and high-
lighted the possibility that neutralization by MPER-spe-
cific antibodies required the recognition of their epitopes
in the context of membrane lipids. The precise window of
action of these antibodies and their modes of epitope rec-
ognition however still await further definition.
Methods
Here we performed detailed time-course studies of the
interaction between virus and the MPER specific antibod-
ies in comparison with neutralizing antibodies IgG1b12
and 2G12 prior to and during the infection of target cells.
Virus binding was assessed directly in an ELISA-based vir-
ion capture assay and infectivity of antibody treated virus
was probed on susceptible target cells (TZM-bl).
Results
We found that, while MPER-specific neutralizing antibod-
ies bind to HIV virions before target cell and receptor
interaction, this interaction is slow in the onset and
requires several hours to reach its maximum. Time-
dependent increase in 2F5 and 4E10 binding to virions is
paralleled by an increase in the antibodies neutralization
activity. Notable, this process is temperature dependent
with lower temperatures obliterating the effect.
Conclusion
In sum our results strongly support the notion that the
MPER of gp41 is accessible for neutralizing antibodies
before receptor engagement but that the accessibility of
the MPER on the virions depends on thermodynamic
rearrangements in the epitope or viral membrane domain.
Based on our observations, we hypothesize that the MPER
on intact virions has a considerable degree of structural
flexibility and is able to sample multiple conformations
including structures occurring during viral entry into tar-
get cells and which expose the region sufficiently to allow
antibody to dock.
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